Navigation Links
US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims

Americas Watchdog's US Drug Watchdog has expanded its national investigation of the drug called Diditek. In April 2008, Actavis Towtowa recalled all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP, all strengths) for oral use, due to a manufacturing defect. Since that time many consumers or their families have received notification of the drugs recall. The US Drug Watchdog wants to talk to any consumer who took this drug and suffered any side affects or complications to include death. Consumers who were exposed to this drug can call the US Drug Watchdog anytime at 866-714-6466.

(PRWEB) June 30, 2008 -- Americas Watchdog's US Drug Watchdog has just expanded its national investigation into the drug called Digitek. According to the Food & Drug Administration (FDA), "the Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions". The best known side affect of this drug is death. If you or a loved one suffered an injury after taking Digitek, the US Drug Watchdog wants to talk with you. A victim or a family member can call the group anytime at 866-714-6466.

What Kind Of Drug Is Digitek?

Digitek is a form of digitalis, a chemical derived from the foxglove plant that has been used as a heart medicine since the 18th century. The medication is sold generically as digoxin by several companies.

The Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions.
Digitalis medicines strengthen the force of the heartbeat by increasing the amount of calcium in the heart's cells. When the medicine reaches the heart muscle, it binds to sodium and potassium receptors. These receptors control the amount of calcium in the heart muscle by stopping the calcium from leaving the cells. As calcium builds up in the cells, it causes a stronger heartbeat. Again if you have taken this drug or were exposed to it please call the US Drug Watchdog at 866-714-6466.

Consumers who took this drug can visit their web site at

So What Happened?

On April 25, 2008 Actavis Towtowa recalled its Digitek tablets because there existed a possibility that tablets with double the appropriate thickness may have been commercially released. The FDA deemed the Digitek recall a Class I recall, meaning that the defective Digitek tables could cause serious health problems or death. Most if not all US consumers have now been told not to take Digitek by their physician or pharmacist. If a family member of a person who was taking Digitek & then died received the recall letter, please call the US Drug Watchdog at 866-714-6466. The recall letters should have been received in early May 2008.

What Are The Risk Health Risks Associated With Digitek?

A double-strength Digitek tablet poses a serious risk of digitalis toxicity in those patients suffering from renal failure. Digitalis toxicity can cause nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, heart palpitations, and bradycardia. Bradycardia is a slower than normal heartbeat rate.Vision changes such as halos or light rings around objects, seeing lights and bright colors, experiencing changes in color perception, blind spots in vision, and blurred vision can also occur. Patients suffering digitalis toxicity can also experience decreased urine output and excessive nighttime urination, overall swelling, decreased consciousness, and difficulty breathing when lying down. At its most severe, death can result from excessive Digitalis intake.

Both Actavis and the FDA said retailers who have Digitek tablets in stock should return the product. Consumers with medical questions should contact their health care providers. Consumers were also can obtain more information on the Digitek recall by calling the US Drug Watchdog at 866-714-6466.

If a family member died or has suffered other side affects related to the possible use of Digitek Americas Watchdog is available to consumers or their family members 24-7 at 866-714-6466

Americas Watchdog and its US Drug Watchdog is all about consumer protection and corporate fair play.


Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. International Watchdog Group Singles Out Resurrection for Anti-Union Violations
2. Union Corruption Watchdog Criticizes GM/UAW Deal on Health Care; Says Congress Should Hold Hearings on Lousy Deal for Retirees
3. New Fish Advice Throws Baby Out With the Bath Water, Says Mercury Watchdog Group
4. Consumer Watchdog Gives HMO Regulator 10 Days to Order Reinstatement of Patients Whose Policies Have Been Illegally Cancelled
5. Consumer Watchdog Applauds L.A. City Attorneys Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same
6. Consumer Watchdog Applauds L.A. City Attorneys Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Immediately Reinstate Coverage
7. Consumer Watchdog Praises CA HMO Regulators Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered
8. Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations
9. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
10. Heart Disease and Diabetes Finally Meet Their Match With Delicious New Snack Bars From WatchDog Nutrition(TM)
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
Related Image:
US Drug Watchdog Expands Its National Investigation Into The Drug Called Digitek, And Would Like To Talk To Possible Victims 
(Date:10/13/2017)... ... 2017 , ... As health professionals work to improve their approach to healthcare, ... doing more than filling out a survey; in many cases health professionals and patients ... health care and research on the importance of active engagement with patients and members ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: